ATILA Biosystems

• Youxiang Wang

  Ceo

Sources: reporter.nih.gov

• National Cancer Institute

  R44, PROGRESS: PRevention of cervical cancer using the Genotyping scREening and Same-day Self-sampling, R44CA272177, US$986.4k, 2022–2025, 21 Aug 2023

Sources: reporter.nih.gov

• Clinical Validation of the Sansure Human Papillomavirus DNA Diagnostic Kit for Use in Primary Cervical Cancer Screening

  Grants or research support, 1 Aug 2026

Sources: pubmed.ncbi.nlm.nih.gov

• DIAGNOSTIC ACCURACY OF VISUAL INSPECTION WITH ACETIC ACID FOR CERVICAL CANCER SCREENING AMONG WOMEN LIVING WITH HUMAN IMMUNODEFICIENCY VIRUS IN OSOGBO, NIGERIA

  medRxiv, 7 Aug 2026